- $1.95bn
- $2.60bn
- $1.10bn
- 38
- 59
- 51
- 48
Annual income statement for Acuren, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 November 30th | 2023 November 30th | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | 10-K |
| Standards: | — | IFRS | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0 | 0 | 1,097 |
| Cost of Revenue | |||
| Gross Profit | — | — | 266 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | — | 1.28 | 1,154 |
| Operating Profit | 0 | -1.28 | -56.3 |
| Total Net Non Operating Interest Income / Expense | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | — | 14 | -123 |
| Provision for Income Taxes | |||
| Net Income After Taxes | — | 14 | -121 |
| Net Income Before Extraordinary Items | |||
| Net Income | — | 14 | -121 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Dilution Adjustment | |||
| Diluted Net Income | 0 | 13.7 | -121 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | — | 0.255 | -0.723 |
| Dividends per Share |